The US Food and Drug Administration approved the use of a booster dose of Pfizer and BioNTech’s COVID-19 vaccine for children aged 5 to 11, allowing anybody above the age of 5 to get a third shot. Before the injections may be given out, the US Centers for Disease Control and Prevention (CDC) must approve them.
In the United States, children under the age of five are not yet eligible for the COVID-19 vaccination. In the face of studies showing that vaccination protection wanes with time, the US government has been pushing for eligible Americans to obtain boosters, and it just allowed a second shot for adults 50 and older. A first booster dosage was given to about 102.3 million individuals.
Booster vaccinations in this age range, according to Dr. Paul Offit of Children’s Hospital of Philadelphia, would have a minimal influence on the pandemic, despite evidence that the additional injections will protect against moderate sickness for three to six months. On Thursday, the CDC will hold a conference of independent consultants to consider vaccination boosters. The director of the agency has the final word on vaccination administration.